日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma

晚期或不可切除黏膜黑色素瘤历史队列的临床特征和对全身治疗的反应

Shoushtari, Alexander N; Bluth, Mark J; Goldman, Debra A; Bitas, Christiana; Lefkowitz, Robert A; Postow, Michael A; Munhoz, Rodrigo R; Buchar, Gauri; Hester, Robert H; Romero, Jacqueline A; Fitzpatrick, Laura J; Weiser, Martin R; Panageas, Katherine S; Wolchok, Jedd D; Chapman, Paul B; Carvajal, Richard D

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.

Cixutumumab 和 temsirolimus 治疗骨和软组织肉瘤患者:一项多中心、开放标签的 2 期试验

Schwartz Gary K, Tap William D, Qin Li-Xuan, Livingston Michael B, Undevia Samir D, Chmielowski Bartosz, Agulnik Mark, Schuetze Scott M, Reed Damon R, Okuno Scott H, Ludwig Joseph A, Keedy Vicki, Rietschel Petra, Kraft Andrew S, Adkins Douglas, Van Tine Brian A, Brockstein Bruce, Yim Vincent, Bitas Christiana, Abdullah Abdul, Antonescu Cristina R, Condy Mercedes, Dickson Mark A, Vasudeva Shyamprasad Deraje, Ho Alan L, Doyle L Austin, Chen Helen X, Maki Robert G